Cargando…

PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY

Detalles Bibliográficos
Autores principales: Fathi, A., Molero, A., Gutierrez, S., Arévalo, M., Yang, H., Buesa, C., Limon, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430636/
http://dx.doi.org/10.1097/01.HS9.0000850252.38175.2e
_version_ 1784779825704075264
author Fathi, A.
Molero, A.
Gutierrez, S.
Arévalo, M.
Yang, H.
Buesa, C.
Limon, A.
author_facet Fathi, A.
Molero, A.
Gutierrez, S.
Arévalo, M.
Yang, H.
Buesa, C.
Limon, A.
author_sort Fathi, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9430636
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94306362022-08-31 PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY Fathi, A. Molero, A. Gutierrez, S. Arévalo, M. Yang, H. Buesa, C. Limon, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430636/ http://dx.doi.org/10.1097/01.HS9.0000850252.38175.2e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Fathi, A.
Molero, A.
Gutierrez, S.
Arévalo, M.
Yang, H.
Buesa, C.
Limon, A.
PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title_full PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title_fullStr PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title_full_unstemmed PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title_short PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY
title_sort pb1850: a dose finding and expansion open label, multicenter study of iadademstat and gilteritinib in patients with relapse/refractory acute myeloid leukemia with mutated flt3: the frida study
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430636/
http://dx.doi.org/10.1097/01.HS9.0000850252.38175.2e
work_keys_str_mv AT fathia pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT moleroa pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT gutierrezs pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT arevalom pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT yangh pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT buesac pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy
AT limona pb1850adosefindingandexpansionopenlabelmulticenterstudyofiadademstatandgilteritinibinpatientswithrelapserefractoryacutemyeloidleukemiawithmutatedflt3thefridastudy